Funded Grants

PI Name PI Organization Title Grant Number Sort ascending Initiative Program Official
Wu, Yun

State University Of New York At Buffalo
United States

Exosomal Thomsen-Friedenreich glycoantigen as a new biomarker for lung cancer screening and early detection 5R21CA267934-02 PAR-20-292 (R21 Clinical Trial Optional) Matthew Young, Ph.D.
Thomas, Christoforos

Methodist Hospital Research Institute
United States

Exploring the role of ER Beta in disease penetrance in individuals with Li-Fraumeni syndrome 5R21CA267386-03 PAR-20-292 (R21 Clinical Trial Optional) Winfred Malone, Ph.D., M.P.H.
Kuhs, Krystle A.

University Of Kentucky
United States

Circulating HPV DNA as a Prediagnostic Marker of Oropharyngeal Cancer 5R21CA267152-02 Wendy Wang, Ph.D., M.Sc.
Smalley, Keiran

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Defining and targeting the epigenetic programs involved in melanoma development 5R21CA267141-02 PAR-20-292 (R21 Clinical Trial Optional) Winfred Malone, Ph.D., M.P.H.
Valdez, Erin G

Stanford University
United States

Circadian regulation of cancer therapy-associated neuroinflammation 5R21CA267135-02 Marge Good, R.N., M.P.H., O.C.N.
Azizoddin, Desiree R

University Of Oklahoma Hlth Sciences Ctr
United States

Leveraging mHealth to deliver integrated pain-CBT, opioid monitoring, and self-management support for advanced cancer patients coping with chronic pain 5R21CA263838-02 Brennan Streck, Ph.D., R.N., M.P.H.
Heinrich, Michael C

Oregon Health & Science University
United States

Novel models for functional profiling of germline SDH variants associated with cancer 5R21CA263400-02 PAR-20-292 (R21 Clinical Trial Optional) Richard Mazurchuk, Ph.D.
King, Suzanne N

University Of Louisville
United States

Mechanisms underlying radiation-induced dysphagia 5R21CA263107-02 PAR-20-292 (R21 Clinical Trial Optional) Nancy J. Emenaker, Ph.D., R.D.N., L.D., F.A.N.D.
Tamrazi, Benita

Children'S Hospital Of Los Angeles
United States

Brain iron accumulation as an in vivo quantifiable biomarker of neurocognitive dysfunction in pediatric brain tumor survivors 5R21CA262978-02 Rachel Altshuler, Ph.D.
Stabile, Laura P.

University Of Pittsburgh At Pittsburgh
United States

Super-Resolution Imaging of Higher-Order Heterochromatin Structure for Early Detection of Lung Carcinogenesis 5R21CA259787-02 PAR-20-292 (R21 Clinical Trial Optional) Claire Zhu, Ph.D.